Join the club for FREE to access the whole archive and other member benefits.

Steven Engle

Chief Executive Officer & Director, CohBar

Steven Engle joined CohBar as Chief Executive Officer and Director in 2019. From 2011 to 2019, he served as the Chief Executive Officer of Averigon, an advisory firm to the life science industry. From 2007 to 2011, Mr. Engle was Chairman, Chief Executive Officer and President of XOMA Corporation. From 1993 to 2006, he held several executive management roles including serving as Chairman and Chief Executive Officer at La Jolla Pharmaceutical Company. Mr. Engle is chairman of Prescient Therapeutics and a director on the boards of AROA Biosurgery and Author-it Software Corporation. He is a former director of the board of the industry associations, BIO, BayBio and BIOCOM. Mr. Engle received a B.S. and M.S. in Electrical Engineering from the University of Texas, Austin.

Visit website: https://www.bloomberg.com/profile/person/1403357

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Company CohBar - Company focused on the research and development of mitochondria based therapeutics.

Steven Engle is also referenced in the following:

Event
Metabesity 2021
11-Oct-2021 to 14-Oct-2021

The Kitalys institute virtual conference targeting key questions that will impact the future of aging and extending healthspan

Steven Engle News

CohBar's lead candidate may initiate clinical trials in 2022

Longevity Technology - 16-Mar-2021

Mitochondrial-based therapy enters IND to tackle IPF and other fibrotic diseases

Read more...